Trimethylamine N-oxide in Myocardial Infarction
Cuvinte cheie
Abstract
Descriere
This study includes patients with their first STEMI. The investigators measure plasma TMAO levels using the frozen plasma at the onset of STEMI and 10 months later (the chronic phase). To assess plaque progression, residual SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score and chronic-phase SYNTAX score are measured. After the chronic-phase assessment of TMAO and SYNTAX score, patients are followed for cardiovascular events including death, myocardial infarction, ischemic stroke, and unstable angina pectoris with coronary revascularization.
Datele
| Ultima verificare: | 12/31/2017 |
| Primul depus: | 01/24/2018 |
| Inscriere estimată trimisă: | 01/24/2018 |
| Prima postare: | 01/31/2018 |
| Ultima actualizare trimisă: | 01/30/2018 |
| Ultima actualizare postată: | 02/04/2018 |
| Data actuală de începere a studiului: | 12/31/2006 |
| Data estimată de finalizare primară: | 12/31/2017 |
| Data estimată de finalizare a studiului: | 12/31/2017 |
Stare sau boală
Fază
Criterii de eligibilitate
| Vârste eligibile pentru studiu | 20 Years La 20 Years |
| Sexe eligibile pentru studiu | All |
| Metoda de eșantionare | Non-Probability Sample |
| Acceptă voluntari sănătoși | da |
| Criterii | Inclusion Criteria: - Patients who admitted to the Yokohama City University Medical Center with the diagnosis of their first STEMI and who underwent primary percutaneous coronary intervention within 12 hours after onset and received follow-up coronary angiogram 10 months after the index intervention. Exclusion Criteria: - none |
Rezultat
Măsuri de rezultate primare
1. MACE [6 years]
Măsuri de rezultate secundare
1. Coronary plaque progression [10 months]
